Showing results (81-90 of 95) with videos related to

Sort By:
Pageof 10
Oncogene|June 14, 2024
Plexin D1 emerges as a novel target in the development of neural lineage plasticity in treatment-resistant prostate cancerBo Chen, Pengfei Xu, Joy C Yang, et al.
Cancer Research Communications|October 23, 2024
PINK1-Mediated Mitochondrial Activity Confers Olaparib Resistance in Prostate Cancer CellsZachary A Schaaf, Shu Ning, Amy R Leslie, et al.
Molecular Cancer Therapeutics|August 5, 2022
Bioengineered BERA-Wnt5a siRNA Targeting Wnt5a/FZD2 Signaling Suppresses Advanced Prostate Cancer Tumor Growth and Enhances Enzalutamide TreatmentShu Ning, Chengfei Liu, Wei Lou, et al.
International Journal of Molecular Sciences|July 15, 2026
Glutamate Ionotropic Kainate Receptors as Therapeutic Targets in Enzalutamide-Resistant and Neuroendocrine Prostate CancerHuan Qu, Pengfei Xu, Joy C Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 15, 2020
Steroid Sulfatase Stimulates Intracrine Androgen Synthesis and is a Therapeutic Target for Advanced Prostate CancerCameron M Armstrong, Chengfei Liu, Liangren Liu, et al.
Oncogene|July 17, 2021
ARVib suppresses growth of advanced prostate cancer via inhibition of androgen receptor signalingChengfei Liu, Cameron M Armstrong, Shu Ning, et al.
Molecular Cancer Therapeutics|December 5, 2025
IGFBP3-SphK1/S1P Signaling Axis Drives Enzalutamide Resistance in Advanced Prostate CancerAmy R Leslie, Shu Ning, Masuda Sharifi, et al.
Oncogene|January 3, 2023
Novel inhibition of AKR1C3 and androgen receptor axis by PTUPB synergizes enzalutamide treatment in advanced prostate cancerJoy C Yang, Pengfei Xu, Shu Ning, et al.
Nature Communications|November 18, 2018
Proteostasis by STUB1/HSP70 complex controls sensitivity to androgen receptor targeted therapy in advanced prostate cancerChengfei Liu, Wei Lou, Joy C Yang, et al.
Molecular Cancer Therapeutics|May 5, 2026
Targeting NDUFS4 Disrupts Oxidative Phosphorylation and Induces Ferroptosis in Olaparib-Resistant Prostate CancerZachary A Schaaf, Shu Ning, Amy R Leslie, et al.
Pageof 10